Skip to content

• Sleep Disturbance Among Patients With Psoriasis and Atopy and Comparison Between Them

• Sleep Disturbance Among Patients With Psoriasis and Atopy and Comparison Between Them

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03864809
Enrollment
150
Registered
2019-03-06
Start date
2019-06-01
Completion date
2020-08-31
Last updated
2019-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disturbance

Brief summary

Comparison between sleep disturbance in atopy and psoriasis and control

Detailed description

Sleep is essential for daytime functioning and health and important for both psychological and physiological wellbeing . A growing body of research indicates that chronic sleep disturbance is associated with impaired quality of life (QoL) and a risk factor for poorer health, for example depression cardiovascular disease, hypertension 1 and diabetes. insomnia, the most common sleep disorder, is a clinical condition defined as difficulties falling asleep and/or maintaining sleep and/or poor sleep quality despite adequate opportunity for sleep resulting in significant daytime impairment. The development of insomnia in healthy populations has a bi-directional relationship with psychological factors such as anxiety, depressive symptoms and stress, and may in clinical populations also be associated with physical symptoms, such as pain. the physical symptoms in psoriasis, such as itch, one would expect a higher prevalence of sleep disturbance in this patient group. On the other hand Sleep disturbance is common also in patients with atopic dermatitis (AD). Patients with AD often have sleep disturbances due to pruritus.

Interventions

BEHAVIORALsleep disturbance

we observe sleep disturbance among patients with psoriasis and atopic dermatitis and control group

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

\- patients with Psoriasis and Patients with A topic dermatitis

Exclusion criteria

* All patient have another dermatological disease

Design outcomes

Primary

MeasureTime frameDescription
severity of the psooriasis (Psoriasis Area and Severity Index)1 hourcalculation of the severity through questionaire , 0 = None 1. = Slight 2. = Moderate 3. = Severe 4. = Very severe

Secondary

MeasureTime frameDescription
.insomnia severity [Insomnia Severity Index (ISI)];1 hourThe Insomnia Severity Index has seven questions. The seven answers are added up to get a total score. When you have your total score Total score categories: 0-7 = No clinically significant insomnia 8-14 = Subthreshold insomnia 15-21 = Clinical insomnia (moderate severity) 22-28 = Clinical insomnia (severe)
sleep quality [Pittsburgh Sleep Quality Index (PSQI)];1 hourThe Pittsburgh Sleep Quality Index (PSQI) is an effective instrument used to measure the quality and patterns of sleep in adults. It differentiates poor from good sleep quality by measuring seven areas (components): subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction over the last month. A total score of 5 or greater is indicative of poor sleep quality. If you scored 5 or more it is suggested that you discuss your sleep habits with a healthcare provider
stress (Perceived Stress Scale);1 hourThe Perceived Stress Scale (PSS) is the most widely used psychological instrument for measuring the perception of stress. It is a measure of the degree to which situations in one's life are appraised as stressful. 0 = Never 1 = Almost Never 2 = Sometimes 3 = Fairly Often 4 = Very Often
2.HRQoL (Dermatology Life Quality Index);1 hourThe aim of this questionnaire is to measure how much your skin problem has affected your life OVER THE LAST WEEK The DLQI is calculated by summing the score of each question resulting in a maximum of 30 and a minimum of 0. The higher the score, the more quality of life is impaired.
and depressive symptoms (Beck Depression Inventory1 hourThis depression inventory can be self-scored 1-10\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_These ups and downs are considered normal 11-16\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ Mild mood disturbance 17-20\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_Borderline clinical depression 21-30\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_Moderate depression 31-40\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_Severe depression over 40\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_Extreme depression
severity of a topic dermatitis1 hourThe eczema area and severity index (EASI) Mild eczema score \< 25 Moderate eczema score \>25 \<50 Severe eczema score \>50
itch (Itch Severity Scale);1 hourThe ISS consists of seven questions that measure the severity of itch and the extent to which QoL is affected. The total score ranges from zero to 21

Contacts

Primary Contactmanai mahmoud, Bachelor's
amanimahmoud43@gmail.com1025191410
Backup Contactsaher abdelmoez, professor
saharsotohy@yahoo.com01008899446

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026